RPID · Rapid Micro Biosystems, Inc.
$2.01
+0.03 (+1.26%)
At close · Jul 27
Market Cap
$91.88M
Shares
46.17M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.99
Open$2.05
Day$1.96–2.05
52W$1.66–4.94
Avg vol 30d221K
Short int842K · 1.8% float · 3.2d
Short vol79%
Last earningsAug 7, 2026
DataJul 2021–Jul 2026
Filing10-Q · May 15
Up next
Next earnings call
Aug 7, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−33%
below
Price vs 50-day avg
+3%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
10%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+18%
trailing
6-month return
−57%
trailing
YTD return
−31%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 46 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.82% of float · ▲ +14.1% MoM · 3.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Squeeze score
50
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
EPS growth
+3%
Y/Y
Free cash flow
$-31.9M
Balance sheet
$1.1M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 13, 2026
Total revenue
· full year 2026
Initiated
$37M – $41M
prior FY $33.59M
midpoint +16.1% Y/Y
Gross margin percentage
· full year 2026
Initiated
20%
Guided vs delivered
· last 1 settled
Full-year total revenue
full year
guided $33M
$33.59M
Beat +1.8%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−33%
Bearish
Price vs 50-day avg
+3%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
1 of 46 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.82% of float · ▲ +14.1% MoM · 3.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $2 · 10%
52-wk high $5
vs 200-day avg -33%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Recurring revenue | $5.1M | first quarter of 2026 | — |
| cumulative systems placed | 190 | full year 2025 | — |
| cumulative systems validated | 155 | full year 2025 | — |
| customer systems validated | 18 | full year 2025 | — |
| Growth Direct systems placed | 28 | full year 2025 | — |
| Non-GAAP adjusted total gross margin percentage non-GAAP | 6% | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RPID
this stock
Rapid Micro Biosystems, Inc.
|
$91.88M | -31.4% | +19.7% | — | 1.8% |
|
ABT
Abbott Laboratories
|
$179.51B | -19.2% | +5.7% | 28.9 | 1.4% |
|
SYK
Stryker Corp
|
$126.60B | -9.0% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$106.51B | -13.9% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.77B | -54.3% | +5.5% | 18.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RPID | -4.8% | +18.5% | -57.5% | +15.0% | -31.4% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -3.1% | +17.8% | -63.8% | +16.2% | -39.6% |